MX2008013783A - Composiciones para el tratamiento y prevención de la hinchazón de los párpados. - Google Patents

Composiciones para el tratamiento y prevención de la hinchazón de los párpados.

Info

Publication number
MX2008013783A
MX2008013783A MX2008013783A MX2008013783A MX2008013783A MX 2008013783 A MX2008013783 A MX 2008013783A MX 2008013783 A MX2008013783 A MX 2008013783A MX 2008013783 A MX2008013783 A MX 2008013783A MX 2008013783 A MX2008013783 A MX 2008013783A
Authority
MX
Mexico
Prior art keywords
agent
vasoconstrictor
effective amount
osmotic
further characterized
Prior art date
Application number
MX2008013783A
Other languages
English (en)
Spanish (es)
Inventor
Matthew Jonathan Chapin
Mark Barry Abelson
Akimitsu Makino
Keith Jeffrey Lane
Original Assignee
Aciex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aciex Inc filed Critical Aciex Inc
Publication of MX2008013783A publication Critical patent/MX2008013783A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
MX2008013783A 2006-04-26 2007-04-26 Composiciones para el tratamiento y prevención de la hinchazón de los párpados. MX2008013783A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79498306P 2006-04-26 2006-04-26
US84547906P 2006-09-18 2006-09-18
PCT/US2007/010177 WO2007127333A2 (en) 2006-04-26 2007-04-26 Compositions for the treatment and prevention of eyelid swelling

Publications (1)

Publication Number Publication Date
MX2008013783A true MX2008013783A (es) 2009-02-05

Family

ID=38656195

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008013783A MX2008013783A (es) 2006-04-26 2007-04-26 Composiciones para el tratamiento y prevención de la hinchazón de los párpados.

Country Status (7)

Country Link
US (3) US8685439B2 (enExample)
EP (1) EP2015733A2 (enExample)
JP (1) JP2009535342A (enExample)
AU (1) AU2007243334A1 (enExample)
CA (1) CA2650592A1 (enExample)
MX (1) MX2008013783A (enExample)
WO (1) WO2007127333A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8685439B2 (en) * 2006-04-26 2014-04-01 Aciex Therapeutics, Inc. Method for the treatment and prevention of eyelid swelling
AU2008325214A1 (en) * 2007-11-08 2009-05-14 Aciex Therapeutics, Inc. Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor
WO2009074853A2 (en) * 2007-12-10 2009-06-18 Promed Research Centre Ophthalmic composition comprising phenylephrine
US8778999B2 (en) 2009-03-05 2014-07-15 Insite Vision Incorporated Non-steroidal anti-inflammatory ophthalmic compositions
EP2470161B1 (en) 2009-08-26 2015-10-07 Mary Kay, Inc. Topical skin care formulations comprising plant extracts
US20120225918A1 (en) 2011-03-03 2012-09-06 Voom, Llc Compositions and Methods for Non-Surgical Treatment of Ptosis
WO2013052770A1 (en) 2011-10-05 2013-04-11 Sanders Jennifer L Methods and compositions for treating foot or hand pain
US20150044136A1 (en) * 2013-08-12 2015-02-12 George H. Scherr Ophthalmological treatment for michobial infections
US9874379B2 (en) * 2014-07-09 2018-01-23 Hamilton Sundstrand Corporation Expendable driven heat pump cycles
US9820954B2 (en) 2015-08-19 2017-11-21 Jenivision Inc. Quantitative peri-orbital application of ophthalmology drugs
CN115006537A (zh) * 2016-01-26 2022-09-06 利维申制药有限公司 α-肾上腺素能药剂的组合物和用途
SG11202100184SA (en) * 2018-07-12 2021-02-25 Ocusoft Inc Anti-allergenic ocular compositions and eyelid cleansing wipes
US11077150B2 (en) * 2018-10-09 2021-08-03 Massoumeh Kharazmi Methods and compositions for treatment of eye conditions
US10799481B1 (en) 2019-05-06 2020-10-13 Rvl Pharmaceuticals, Inc. Compositions and methods for treating ocular disorders
BR112022010038A2 (pt) * 2019-11-26 2022-08-16 Standard Of Care Corp Composições de hialuronidase e métodos de uso das mesmas para tratar o encovamento periorbital e deformidades do sulco lacrimal
BR112022026911A2 (pt) * 2020-09-11 2023-03-28 Intratus Nevada Inc Composições e métodos para tratar presbiopia, hipermetropia, astigmatismo, diminuição da estereopsia e diminuição da sensibilidade ao contraste
CN120112299A (zh) 2022-09-29 2025-06-06 爱多拉动物健康公司 用于治疗疼痛和其他医学病症的硫酸化糖胺聚糖及其衍生片段的储存稳定的制剂

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2618428A (en) * 1947-01-27 1952-11-18 John K M Harrison Shock resistant container
JPS6056684B2 (ja) 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
US4271143A (en) * 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
US4407792A (en) * 1979-05-09 1983-10-04 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
LU83173A1 (fr) * 1981-02-27 1981-06-05 Oreal Nouvelles compositions cosmetiques pour le traitement des cheveux et de la peau contenant une poudre resultant de la pulverisation d'au moins une plante et un agent de cohesion
US4407791A (en) * 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
US4454151A (en) * 1982-03-22 1984-06-12 Syntex (U.S.A.) Inc. Use of pyrrolo pyrroles in treatment of ophthalmic diseases
ATE151286T1 (de) * 1983-11-14 1997-04-15 Columbia Lab Inc Bioadhäsive mittel
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
IT1248014B (it) 1991-06-07 1995-01-05 Inverni Della Beffa Spa Preparazioni oftalmiche a rilascio protratto
JP3781792B2 (ja) * 1993-12-27 2006-05-31 千寿製薬株式会社 ジフルプレドナート含有点眼用懸濁液剤
US5556848A (en) * 1993-12-27 1996-09-17 Senju Pharmaceutical Co., Ltd. Ophthalmic suspension containing diflupredonate
US5811446A (en) * 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
US7691829B2 (en) * 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
US6274626B1 (en) 1998-12-22 2001-08-14 Bausch & Lomb Incorporated Pheniramine-containing compositions and method for treating allergic responses
EP1194136B1 (fr) * 1999-06-08 2004-02-18 Naturveda Composition non solide pour application locale comprenant du glycerol et un extrait d'alchemille vulgaire
WO2000078297A2 (de) * 1999-06-22 2000-12-28 Boehringer Ingelheim International Gmbh Stabile xylometazolin- und oxymetazolinlösung
JP2001187728A (ja) 1999-12-28 2001-07-10 Lion Corp 眼科用組成物
DE10000612A1 (de) 2000-01-10 2001-07-19 Min Becker Flüssigkeitspräparate für Augen- und Nasen-Tropfen bzw. Nasenspray ohne Konservierungsmittel
WO2001054684A1 (en) * 2000-01-26 2001-08-02 Kyorin Pharmaceutical Co., Ltd. Eye drops
CA2423354C (en) * 2000-09-20 2009-12-15 Lee Shahinian Jr. Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications
JP2002308775A (ja) 2001-04-06 2002-10-23 Rohto Pharmaceut Co Ltd 外用組成物
US6806364B2 (en) * 2002-07-29 2004-10-19 Ast Products, Inc. Ophthalmic compositions
JP2004123729A (ja) 2002-09-09 2004-04-22 Santen Pharmaceut Co Ltd ラタノプロストを有効成分とする澄明な点眼液
US7714011B2 (en) * 2002-09-13 2010-05-11 Zicam, Llc Compositions to reduce congestion and methods for application thereof to the nasal membrane
US20050059639A1 (en) * 2003-09-11 2005-03-17 Wei Edward T. Ophthalmic compositions and method for treating eye discomfort and pain
US7288263B2 (en) 2004-09-13 2007-10-30 Evera Laboratories, Llc Compositions and methods for treatment of skin discoloration
DK2486942T3 (en) 2004-11-24 2019-01-28 Meda Pharmaceuticals Inc COMPOSITIONS CONTAINING AZELASTINE AND PROCEDURES FOR USING IT
JP2006232792A (ja) 2005-02-21 2006-09-07 Aile De Beaute:Kk 肌老化改善化粧料
JP5292277B2 (ja) 2006-03-31 2013-09-18 ビスタコン・フアーマシユーチカルズ・エルエルシー 眼アレルギーの処置
US8685439B2 (en) * 2006-04-26 2014-04-01 Aciex Therapeutics, Inc. Method for the treatment and prevention of eyelid swelling

Also Published As

Publication number Publication date
EP2015733A2 (en) 2009-01-21
US8685439B2 (en) 2014-04-01
JP2009535342A (ja) 2009-10-01
WO2007127333A3 (en) 2008-08-07
US20120021072A1 (en) 2012-01-26
US20140161903A1 (en) 2014-06-12
US20070264318A1 (en) 2007-11-15
CA2650592A1 (en) 2007-11-08
AU2007243334A1 (en) 2007-11-08
WO2007127333A2 (en) 2007-11-08

Similar Documents

Publication Publication Date Title
US8685439B2 (en) Method for the treatment and prevention of eyelid swelling
US20210177807A1 (en) Compositions for the treatment and prevention of eyelid swelling
CA2705050A1 (en) Compositions for the treatment and prevention of eyelid swelling
US10912765B2 (en) Compositions and methods for non-surgical treatment of ptosis
US20070297981A1 (en) Formulations and methods for treating dry eye
US20070254841A1 (en) Formulations and methods for treating dry eye
US20090010850A1 (en) Formulations and methods for treating dry eye
KR20140076587A (ko) 노안, 경도 원시 및 불규칙한 난시의 치료를 위한 조성물 및 방법
US20080039398A1 (en) Formulations and methods for treating dry eye
US20070299124A1 (en) Formulations and methods for treating dry eye
CN101460152A (zh) 治疗以及预防眼皮肿胀的组合物
US20210052582A1 (en) Methods of use and pharmaceutical compositions of a selective syk inhibitor

Legal Events

Date Code Title Description
HC Change of company name or juridical status

Owner name: KYPHON SRL

FA Abandonment or withdrawal